CRISPR/Cas9 technology generated an arginine to tryptophan substitution at amino acid 171 (R171W). The R171W mutation is found in the majority of Immunodeficiency 50 (X-linked moesin associated immunodeficiency) patients. (J:320965)
查看原文 参与反馈
CRISPR/Cas9 technology generated an arginine to tryptophan substitution at amino acid 171 (R171W). The R171W mutation is found in the majority of Immunodeficiency 50 (X-linked moesin associated immunodeficiency) patients. (J:320965)